Retatrutide Explained: The Triple-Hormone Weight Loss Shot That Could Replace Ozempic
About this episode
Retatrutide is being called the future of weight loss, but what makes it so different from Ozempic and tirzepatide? In this episode, we break down exactly how retatrutide works as a powerful triple agonist targeting GLP-1, GIP, and glucagon, and why early research is showing jaw-dropping fat loss results that may rival bariatric surgery. We cover the science, benefits, potential side effects, and what this breakthrough could mean for the future of obesity and metabolic health.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect
The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect
The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect
Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect
Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect